
Genetic Glimpses into Glaucoma 1, Open Angle, A: A New Dawn in Diagnosis and Treatment
Explore how genetic testing and biomarkers are transforming diagnosis and treatment for Glaucoma 1, open angle, A, enabling personalized and early intervention.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing and biomarkers are transforming diagnosis and treatment for Glaucoma 1, open angle, A, enabling personalized and early intervention.

Explore how genetic testing unveils the causes of glomuvenous malformation, enhancing diagnosis and guiding treatment plans for this rare vascular condition.

Explore the role of genetic testing in diagnosing and managing PGK1 deficiency, a rare glycogen storage disease, and its impact on personalized treatment strategies.

Explore how genetic testing enhances diagnosis and treatment of Gray Platelet Syndrome, a rare inherited disorder, by identifying NBEAL2 mutations and tailoring care.

Explore how genetic testing aids in diagnosing Hand-foot-genital Syndrome, offering early intervention, personalized care, and family planning guidance.

Unlock the potential of genetic testing in hawkinsinuria management. Early diagnosis, personalized care, and informed family planning improve patient outcomes.

Explore how genetic testing identifies enzyme deficiencies and mutations in Heinz body anemia, aiding in accurate diagnosis and personalized treatment plans.

Unlock early detection and prevention of Hereditary Diffuse Gastric Adenocarcinoma with genetic testing. Explore personalized risk assessments and tailored treatments.